Clinical Study

Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation

Figure 1

Adapted CONSORT 2010 Flow Diagram. Distribution of all potential and definite participants at each stage of the study. CsA, cyclosporine A; MMF, mycophenolate mofetil.